top of page
A New Approach to Drug Discovery
The human body is a holistic system. Its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs.
Now it's time to make a change.
Xellar Biosystems is a Wet Artificial Intelligence (AI) biotechnology company, combining machine learning and AI with large-scale wet-lab experiments, tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.
Employ a range of human-relevant Organ-on-a-chip models that mimic human biology by combining human cell sourcing, an organ-specific microenvironment, and tissue-relevant mechanical stimuli
Employ high throughput screening, high content imaging and artificial intelligence, machine learning data analysis to produce a rich profile for different cell populations suitable for detecting subtle biologically relevant phenotypes
Employ microfluidic-based Organ-on-a-Chip technology that is designed and developed for scalability and high throughput lab automation to meet drug discovery and development needs
bottom of page